Oritavancin In Vitro Activity Against a Collection of Molecularly-characterized Staph and Enterococci with Elevated Linezolid MICs
Oritavancin In Vitro Activity Against a Collection of Molecularly-characterized Staph and Enterococci with Elevated Linezolid MICs, Lead author: Mendes RE, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA